Biotech

All Articles

Amgen documents first period 3 gain for $400M dermatitis medicine

.Amgen has shared (PDF) the initial period 3 records on its $400 thousand dermatitis medicine, conne...

Biogen, UCB document stage 3 lupus win after failing earlier test

.Biogen as well as UCB's bet one's bottom dollar advancing in to period 3 on the back of a failed st...

Aptadir hopes brand new RNA preventions can turn around challenging cancers cells

.Italian biotech Aptadir Rehabs has released along with the guarantee that its own pipe of preclinic...

Wave surfs DMD excellence to regulators' doors, sending stockpile

.Wave Life Sciences has actually fulfilled its own target in a Duchenne muscular dystrophy (DMD) stu...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, taking...

Achilles droplets tissue treatment system, supports for cutbacks after missing out on 'office viability' targets

.Achilles Therapeutics has actually shreded its own approach. The British biotech is actually stoppi...

Aligos trumpets stage 2 MASH win, slashing liver excess fat around 46%

.Aligos Therapies is proclaiming a midstage gain in metabolic-dysfunction affiliated steatohepatitis...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job establishing brand-new antifungals has actually received a significant ...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Having currently scooped up the united state legal rights to Capricor Therapeutics' late-stage Duch...

FDA scraps adcomm for Applied's rare ailment drug

.After pushing back the choice date for Applied Therapeutics' metabolic ailment drug govorestat, the...